Skip to main content

Table 2 Relative abundance of bacteria of colonic samples

From: Therapeutic potential of an intestinotrophic hormone, glucagon-like peptide 2, for treatment of type 2 short bowel syndrome rats with intestinal bacterial and fungal dysbiosis

Bacterial taxa

Sham

SBS

GLP2.SBS

Bacteroidetes.P

 Bacteroides.G

0.55 (0.42–1.12)

0.00 (0.00–0.01) *

0.00 (0.00–0.00) **

 Odoribacter.G

0.75 (0.48–1.15)

0.00 (0.00–0.00) **

0.00 (0.00–0.00) **

 Prevotella.G

6.40 (4.63–8.32)

0.00 (0.00–0.00) **

0.00 (0.00–0.02) *

Firmicutes.P

 Lachnospiraceae.F

3.35 (2.49–4.01)

0.00 (0.00–0.21) *

0.02 (0.00–0.20) *

 Coprococcus.G

0.44 (0.23–0.63)

0.00 (0.00–0.00) **

0.00 (0.00–0.00) **

 Dorea.G

0.04 (0.02–0.36)

0.00 (0.00–0.00) **

0.0000 (0.00–0.00) **

 Ruminococcaceae.F

5.73 (4.48–7.34)

0.00 (0.00–0.00) *

0.00 (0.00–0.00) *

 Oscillospira.G

1.55 (1.23–1.98)

0.00 (0.00) **

0.00 (0.00) *

 Ruminococcus.G

1.70 (1.29–2.34)

0.00 (0.00–0.00) *

0.00 (0.00–0.00) *

 Clostridium.G

0.09 (0.05)

15.10 (11.40) **

33.55 (12.67) ***#

Verrucomicrobia.P

 Akkermansia.G

33.90 (23.69–39.75)

0.00 (0.00–0.00) *

0.00 (0.00–0.00) *

Proteobacteria.P

 Proteus.G

0.00 (0.00–0.00)

2.01 (1.23–2.37) **

0.02 (0.02–0.05) #

  1. Data were expressed as percentages of total sequences. For data passed normality test, one-way ANOVA and Tukey’s multiple comparisons test were used, and data were shown as mean (SD). Otherwise, Kruskal-Wallis and Dunn’s multiple comparisons test were used, and data were shown as median and IQR
  2. .P Phylum, F Family, G Genus
  3. *P < 0.05; **P < 0.01; ***P < 0.001 compared with Sham group; #P < 0.05 compared with SBS group